Pilot Study of Intraperitoneal Administration of Triamcinolone Acetonide for Cancerous Ascites in Patients With End-Stage Gynecological Cancer
- 1 July 2014
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 24 (6) , 1093-1097
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Use of Intraperitoneal Triamcinolone Acetonide for the Management of Recurrent Malignant Ascites in a Patient with Non-Hodgkin's LymphomaJournal of Pain and Symptom Management, 2008
- Malignant ascites: Systematic review and guideline for treatmentEuropean Journal of Cancer, 2006
- A Phase II Trial of Triamcinolone Hexacetanide for Symptomatic Recurrent Malignant AscitesJournal of Pain and Symptom Management, 2000
- Intraperitoneal Pressures and Clinical Parameters of Total Paracentesis for Palliation of Symptomatic Ascites in Ovarian CancerGynecologic Oncology, 1998
- Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytesBritish Journal of Dermatology, 1997
- Reinfusion of Concentrated Ascitic Fluid versus Total Paracentesis (A Randomized Prospective Trial)Digestive Diseases and Sciences, 1997
- Induction of Vascular Endothelial Growth Factor by Platelet-Activating Factor and Platelet-Derived Growth Factor is Downregulated by CorticosteroidsAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Management of symptomatic malignant ascites with diuretics: Two case reports and a review of the literatureJournal of Pain and Symptom Management, 1995
- Percutaneous denver peritoneovenous shunt insertionThe American Journal of Surgery, 1990
- Control of malignant ascites with spironolactoneBritish Journal of Surgery, 1982